These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6909499)

  • 1. Effect of Ro 4-1284 on audiogenic seizure susceptibility and intensity in epilepsy-prone rats.
    Jobe PC; Brown RD; Dailey JW
    Life Sci; 1981 May; 28(18):2031-8. PubMed ID: 6909499
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain norepinephrine and convulsions in the genetically epilepsy-prone rat: sex-dependent responses to Ro 4-1284 treatment.
    Mishra PK; Dailey JW; Reigel CE; Jobe PC
    Life Sci; 1988; 42(11):1131-7. PubMed ID: 3347143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Ro 4-1284 on electrically-induced spinal cord seizures and on spinal cord norepinephrine and 5-hydroxytryptamine levels.
    Jobe PC; Ray TB; Geiger PF; Bourn WM
    Res Commun Chem Pathol Pharmacol; 1977 Dec; 18(4):601-12. PubMed ID: 243955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innately hearing impaired Sprague-Dawley rats exhibit audiogenic seizure susceptibility following monoamine depletion.
    Reigel CE; Faingold CL
    Proc West Pharmacol Soc; 1993; 36():267-71. PubMed ID: 8378388
    [No Abstract]   [Full Text] [Related]  

  • 5. Depletion of epinephrine in rat hypothalamus by Ro 4-1284: influence of pargyline and harmaline.
    Fuller RW; Hemrick-Luecke SK
    Brain Res Bull; 1980; 5(5):589-91. PubMed ID: 6903452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms underlying modifications in the severity of audiogenic convulsions.
    Lehmann A
    Life Sci; 1977 Jun; 20(12):2047-59. PubMed ID: 587242
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of 5-hydroxytryptamine synthesis in brain by monamine-depleting drugs.
    Saner A; Pletscher A
    J Pharm Pharmacol; 1978 Feb; 30(2):115-7. PubMed ID: 24096
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis of potential antineoplastic agents XXVI: 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2H-benzo[a]2-quinolizinone derivatives.
    Popp FD; Watts RF
    J Pharm Sci; 1978 Jun; 67(6):871-3. PubMed ID: 248062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ways of increasing resistance of renal transplant to thermal ischemia].
    Savchenko NE; Skobeius IA; Soklakov VI; Pilotovich VS
    Urol Nefrol (Mosk); 1977; (5):72-6. PubMed ID: 144344
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of pargyline pretreatment on the enhancement of the exocytotic release of norepinephrine during nerve stimulation which is induced by a benzoquinolizine compound with reserpine-like properties.
    Langley AE; Weiner N
    J Pharmacol Exp Ther; 1980 Jun; 213(3):534-8. PubMed ID: 6907314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of L-dopa, GPA 1734 and other agents on basement membrane biosynthesis.
    Maragoudakis ME; Kalinsky HJ; Wasvary J
    J Pharmacol Exp Ther; 1978 Feb; 204(2):372-83. PubMed ID: 202695
    [No Abstract]   [Full Text] [Related]  

  • 12. A benzo[a]quinolizine derivative with a neuroleptic-like action on cerebral monoamine turnover.
    Saner A; Pletscher A
    J Pharmacol Exp Ther; 1977 Dec; 203(3):556-63. PubMed ID: 21955
    [No Abstract]   [Full Text] [Related]  

  • 13. Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. V. Enhanced release associated with a granular effect of a benzoquinolizine derivative with reserpine-like properties.
    Cubeddu LX; Weiner N
    J Pharmacol Exp Ther; 1975 Jun; 193(3):757-75. PubMed ID: 239214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain areas involved in the catecholamine mediated regulation of electroshock seizure intensity.
    Stull RE; Jobe PC; Geiger PF
    J Pharm Pharmacol; 1977 Jan; 29(1):8-11. PubMed ID: 13193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of lithium chloride administered in combination with methamphetamine or a reserpine- like drug on brain norepinephrine and dopamine metabolism in rats].
    Nozu T; Furukawa T
    Nihon Yakurigaku Zasshi; 1976 Sep; 72(6):715-23. PubMed ID: 1051410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a reserpine-like agent on the release and metabolism of [3H]NA in cell bodies and terminals.
    Filinger EJ
    Gen Pharmacol; 1994 Sep; 25(5):1039-43. PubMed ID: 7835622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of methamphetamine and a reserpine-like drug on norepinephrine and dopamine metabolism in the rat brain].
    Nozu T; Furukawa T
    Nihon Yakurigaku Zasshi; 1976 May; 72(4):445-51. PubMed ID: 1049210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antihypertensive activity of a series of spiro[1,3,4,6,7,11b-hexahydro-2H-benzo[a]quinolizine-2,5'-oxazolidin-2'-one]s.
    Caroon JM; Clark RD; Kluge AF; Lee CH; Strosberg AM
    J Med Chem; 1983 Oct; 26(10):1426-33. PubMed ID: 6312043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs and PGO waves in the lateral geniculate body of the curarized cat. I. PGO wave activity induced by Ro 43284 and by p-chlorophenylalanine (PCPA) as a basis for neuropharmacological studies.
    Ruch-Monachon MA; Jalfre M; Haefely W
    Arch Int Pharmacodyn Ther; 1976 Feb; 219(2):251-68. PubMed ID: 132146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forced swimming in rats: hypothermia, immobility and the effects of imipramine.
    Porsolt RD; Deniel M; Jalfre M
    Eur J Pharmacol; 1979 Aug; 57(4):431-6. PubMed ID: 258612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.